Information for the public
Mycophenolate is a type of drug called an 'immunosuppressant', which works by stopping the body's immune system from working normally. It is licensed in the UK to be used after someone has had an organ transplant, to try and stop the body from rejecting their new organ.
Treatments for systemic lupus erythematosus (or SLE for short) include non-steroidal anti‑inflammatory drugs (or NSAIDs for short) such as ibuprofen, diclofenac and naproxen, corticosteroids (such as prednisolone), hydroxychloroquine, and immunosuppressants (such as azathioprine, methotrexate, cyclophosphamide, and mycophenolate). Some of these treatments, including mycophenolate, are not licensed specifically for treating SLE, and so their use would be 'off-label'.